Kiniksa Pharmaceuticals, Ltd.
NASDAQ:KNSA
22.99 (USD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 107.954 | 122.715 | 122.47 | 114.038 | 46.928 | 307.304 | 45.555 | 55.97 |
| Short Term Investments
| 98.417 | 67.893 | 59.731 | 209.444 | 186.452 | 235.328 | 0 | 0 |
| Cash and Short Term Investments
| 206.371 | 190.608 | 182.201 | 323.482 | 233.38 | 307.304 | 45.555 | 55.97 |
| Net Receivables
| 21.266 | 20.316 | 3.985 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 31.122 | 21.599 | 3.675 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 17.538 | 10.537 | 6.585 | 9.557 | 8.247 | 6.446 | 1.444 | 0.259 |
| Total Current Assets
| 276.297 | 243.06 | 196.446 | 333.249 | 241.627 | 313.75 | 47.104 | 56.334 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 12.665 | 7.043 | 8.384 | 10.617 | 8.325 | 6.356 | 0.125 | 0.084 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 17.25 | 18.25 | 19.25 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 17.25 | 18.25 | 19.25 | 0 | -0.21 | -0.21 | 0 | 0 |
| Long Term Investments
| -0 | 0 | 0 | 0 | 0.21 | 0.21 | 0 | 0 |
| Tax Assets
| 219.283 | 185.495 | 0 | 0.01 | 4.372 | 1.216 | 0.238 | 0.041 |
| Other Non-Current Assets
| 0.827 | 5.824 | 8.72 | 5.588 | 0.21 | 0.643 | 0.025 | 0.008 |
| Total Non-Current Assets
| 250.025 | 216.612 | 36.354 | 16.215 | 12.907 | 8.215 | 0.388 | 0.133 |
| Total Assets
| 526.322 | 459.672 | 232.8 | 349.464 | 254.534 | 321.965 | 47.492 | 56.467 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 8.246 | 7.899 | 1.868 | 0.503 | 5.693 | 10.918 | 1.218 | 0.212 |
| Short Term Debt
| 2.253 | 3.301 | 3.381 | 2.107 | 1.697 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0.307 | 12 | 38.031 | 29.199 | 20.415 | 0 | 0 | 0 |
| Other Current Liabilities
| 44.614 | 15.967 | -0.324 | -0.466 | -5.668 | 20.718 | 14.994 | 1.878 |
| Total Current Liabilities
| 63.666 | 47.066 | 44.824 | 31.846 | 27.83 | 42.554 | 17.43 | 2.302 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 10.005 | 2.618 | 2.669 | 4.878 | 0.955 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 11.954 | 12 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 1.216 | 0 | 0 |
| Other Non-Current Liabilities
| 1.858 | 1.839 | 0.27 | 0.805 | 0.326 | -1.072 | 119.77 | 79.897 |
| Total Non-Current Liabilities
| 23.817 | 16.457 | 2.939 | 5.683 | 1.281 | 0.144 | 119.77 | 79.897 |
| Total Liabilities
| 87.483 | 63.523 | 47.763 | 37.529 | 29.111 | 42.698 | 137.2 | 82.199 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 119.77 | 79.897 |
| Common Stock
| 0.02 | 0.019 | 0.018 | 0.018 | 0.015 | 0.013 | 0.001 | 0.001 |
| Retained Earnings
| -477.95 | -492.034 | -675.397 | -517.473 | -356.092 | -194.225 | -90.998 | -26.125 |
| Accumulated Other Comprehensive Income/Loss
| 0.006 | 0.044 | -0.066 | -0.034 | 0.033 | -0.004 | -0.052 | -0.024 |
| Other Total Stockholders Equity
| 916.763 | -0.063 | 0.048 | 0.016 | -0.048 | -0.009 | -118.429 | -79.481 |
| Total Shareholders Equity
| 438.839 | -492.034 | -675.397 | -517.473 | -356.092 | -194.225 | -89.708 | -25.732 |
| Total Equity
| 438.839 | -492.034 | -675.397 | -517.473 | -356.092 | -194.225 | -89.708 | -25.732 |
| Total Liabilities & Shareholders Equity
| 526.322 | -428.511 | -627.634 | -479.944 | -326.981 | -151.527 | 47.492 | 56.467 |